HighTower Advisors’s Immunovant IMVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$534K Buy
33,392
+119
+0.4% +$1.9K ﹤0.01% 2456
2025
Q1
$569K Buy
33,273
+238
+0.7% +$4.07K ﹤0.01% 2339
2024
Q4
$818K Sell
33,035
-189
-0.6% -$4.68K ﹤0.01% 2106
2024
Q3
$947K Buy
33,224
+7,259
+28% +$207K ﹤0.01% 1956
2024
Q2
$685K Sell
25,965
-1,379
-5% -$36.4K ﹤0.01% 2092
2024
Q1
$884K Buy
27,344
+21
+0.1% +$679 ﹤0.01% 1875
2023
Q4
$1.15M Buy
27,323
+3,000
+12% +$126K ﹤0.01% 1764
2023
Q3
$933K Buy
24,323
+76
+0.3% +$2.92K ﹤0.01% 1811
2023
Q2
$460K Hold
24,247
﹤0.01% 2255
2023
Q1
$376K Hold
24,247
﹤0.01% 2282
2022
Q4
$431K Hold
24,247
﹤0.01% 2207
2022
Q3
$135K Hold
24,247
﹤0.01% 2681
2022
Q2
$94K Hold
24,247
﹤0.01% 2768
2022
Q1
$134K Hold
24,247
﹤0.01% 2894
2021
Q4
$206K Buy
+24,247
New +$206K ﹤0.01% 2734
2021
Q1
Sell
-4,600
Closed -$209K 2891
2020
Q4
$209K Buy
+4,600
New +$209K ﹤0.01% 2139